These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3979005)

  • 1. Etretinate kinetics during chronic dosing in severe psoriasis.
    Massarella J; Vane F; Buggé C; Rodriguez L; Cunningham WJ; Franz T; Colburn W
    Clin Pharmacol Ther; 1985 Apr; 37(4):439-46. PubMed ID: 3979005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the retinoids.
    Lucek RW; Colburn WA
    Clin Pharmacokinet; 1985; 10(1):38-62. PubMed ID: 3882304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
    Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F
    J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Schrøder H; Kragballe K
    J Clin Pharmacol; 1990 Sep; 30(9):802-7. PubMed ID: 2277127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of meals on the kinetics of etretinate.
    Colburn WA; Gibson DM; Rodriguez LC; Buggé CJ; Blumenthal HP
    J Clin Pharmacol; 1985; 25(8):583-9. PubMed ID: 3841130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
    Brazzell RK; Colburn WA
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M; Paravicini U
    J Am Acad Dermatol; 1984 Apr; 10(4):632-8. PubMed ID: 6715613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of retinoids in the treatment of psoriasis.
    Warren EW; Khanderia U
    Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
    Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with low-dose etretinate and eicosapentaenoic acid for psoriasis vulgaris.
    Danno K; Sugie N
    J Dermatol; 1998 Nov; 25(11):703-5. PubMed ID: 9863281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline of plasma concentrations of etretinate and its main metabolite after treatment.
    Lauharanta J; Paravicini U; Kanerva L; Lassus A
    Arch Dermatol Res; 1982; 274(3-4):377-9. PubMed ID: 7165382
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment.
    Meyer E; de Bersaques J; Lambert WE; de Leenheer AP; Kint AH
    Acta Derm Venereol; 1993 Apr; 73(2):113-5. PubMed ID: 8103254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etretinate. Persistent serum levels after long-term therapy.
    DiGiovanna JJ; Zech LA; Ruddel ME; Gantt G; Peck GL
    Arch Dermatol; 1989 Feb; 125(2):246-51. PubMed ID: 2913962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects.
    Park HD; Kim HK; Chun MR; Kim JW; Kim DW; Lee JH; Huh WS; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):476-82. PubMed ID: 19640355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.